Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in SGMT — Sagimet Biosciences Inc.

CIK 886982 NEW YORK, NY
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,867,734
+$4,983,357 QoQ
Shares Held
759,086
+348.5% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 122 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. SGMT ranks #186 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in SGMT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,867,734 759,086
2026-03-31 $884,377 169,259
2025-12-31 $745,600 125,946
2025-09-30 $104,217 15,192
2025-06-30 $141,892 18,621
2025-03-31 $76,945 23,603
2024-12-31 $598,801 133,067
2024-09-30 $367,631 132,719
2024-06-30 $896,340 262,088
2024-03-31 $161,223 29,746
2023-09-30 $172,955 19,654